X-73447371-C-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_005193.2(CDX4):c.118C>A(p.Pro40Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000587 in 1,208,619 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 30 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000090 ( 0 hom., 3 hem., cov: 23)
Exomes 𝑓: 0.000056 ( 0 hom. 27 hem. )
Consequence
CDX4
NM_005193.2 missense
NM_005193.2 missense
Scores
9
8
Clinical Significance
Conservation
PhyloP100: 2.67
Genes affected
CDX4 (HGNC:1808): (caudal type homeobox 4) This gene encodes a member of a small subfamily of homeobox containing transcription factors. The encoded protein may regulate homeobox gene expression during anteroposterior patterning and hematopoiesis. [provided by RefSeq, Aug 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP6
Variant X-73447371-C-A is Benign according to our data. Variant chrX-73447371-C-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 2464621.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS2
High Hemizygotes in GnomAd4 at 3 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDX4 | NM_005193.2 | c.118C>A | p.Pro40Thr | missense_variant | 1/3 | ENST00000373514.3 | NP_005184.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDX4 | ENST00000373514.3 | c.118C>A | p.Pro40Thr | missense_variant | 1/3 | 1 | NM_005193.2 | ENSP00000362613.1 |
Frequencies
GnomAD3 genomes AF: 0.0000901 AC: 10AN: 110939Hom.: 0 Cov.: 23 AF XY: 0.0000904 AC XY: 3AN XY: 33195
GnomAD3 genomes
AF:
AC:
10
AN:
110939
Hom.:
Cov.:
23
AF XY:
AC XY:
3
AN XY:
33195
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000660 AC: 12AN: 181764Hom.: 0 AF XY: 0.0000753 AC XY: 5AN XY: 66398
GnomAD3 exomes
AF:
AC:
12
AN:
181764
Hom.:
AF XY:
AC XY:
5
AN XY:
66398
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000556 AC: 61AN: 1097680Hom.: 0 Cov.: 31 AF XY: 0.0000744 AC XY: 27AN XY: 363074
GnomAD4 exome
AF:
AC:
61
AN:
1097680
Hom.:
Cov.:
31
AF XY:
AC XY:
27
AN XY:
363074
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000901 AC: 10AN: 110939Hom.: 0 Cov.: 23 AF XY: 0.0000904 AC XY: 3AN XY: 33195
GnomAD4 genome
AF:
AC:
10
AN:
110939
Hom.:
Cov.:
23
AF XY:
AC XY:
3
AN XY:
33195
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ExAC
AF:
AC:
6
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 16, 2023 | The c.118C>A (p.P40T) alteration is located in exon 1 (coding exon 1) of the CDX4 gene. This alteration results from a C to A substitution at nucleotide position 118, causing the proline (P) at amino acid position 40 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | CDX4: BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Uncertain
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
N
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Gain of phosphorylation at P40 (P = 0.0333);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at